5-(2-(1h-indol-3-yl))-ethyl)- piperazin-2-one derivatives for use in the treatment of viral infections by viruses of the family coronaviridae

The present invention relates to new derivatives of 5-(2-(1H-indol-3-yl)ethyl-2-piperazin-2-one or pharmaceutically acceptable salts thereof and to combinations of said compounds with other active ingredients, for use in the treatment and/or prevention of viral infections by viruses from the family Coronaviridae, to the use of said compound or its combinations in the manufacture of a medicament for the treatment or prevention of said diseases and to a method of treating and/or preventing said diseases by administration of said compound or its combinations.